Company / Capital Expenditures
Avidity Biosciences, Inc. Capital Expenditures History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$13.3M
FY2025
5-year range
$2.8M / $13.3M
FY2021-FY2025
Trend
+88.5%
vs FY2024
Sector context
#53 of 194
Health Care
What the data says
At $13M, Avidity Biosciences, Inc.'s capital expenditures ranks #53 of 194 in the Health Care sector. Capital Expenditures has increased for 3 consecutive years, from $3M in FY2022 to $13M in FY2025.
Based on SEC 10-K filings.
$13M in FY2025 with a 5-year CAGR of +64.9%.
Improved from $4M to $13M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +67.7%
- 5-Year CAGR
- +64.9%
- 10-Year CAGR
- -
Sector benchmark
#53 of 194 in Health CareTop 27% of 194This company $13.3M Sector average $117.5M
▼
-88.7% below sector average
Key checks
Key Insights
- Avidity Biosciences, Inc.'s capital expenditures has grown for 3 consecutive years.
- 5-year CAGR of +64.9%, indicating consistent growth.
- In FY2025, capital expenditures increased 88.5% year-over-year.
- Ranks #53 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.3M | +88.5% |
| FY2024 | $7.1M | +67.1% |
| FY2023 | $4.2M | +49.8% |
| FY2022 | $2.8M | -24.5% |
| FY2021 | $3.7M | +242.5% |
| FY2020 | $1.1M | +364.7% |
| FY2019 | $235.0K | +379.6% |
| FY2018 | $49.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026